Patent details

EP2918604 Title: Treatment of pediatric acute lymphoblastic leukemia

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2918604
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP15154416.0
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Germany (DE)
Publications:

Dates

Filing date:
06/11/2009
Grant date:
20/12/2017
EP Publication Date:
16/09/2015
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
15/03/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
20/12/2017
EP B1 Publication Date:
20/12/2017
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
05/11/2029
Lapsed By Expiration Date:
Patent Validated Date:
29/03/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
20/12/2017
 
 

 

Name:
Amgen Research (Munich) GmbH
Address:
Staffelseestrasse 2, 81477 MÜNCHEN, Germany (DE)

Agent

Name:
ir. A.R. Aalbers
From:
28/03/2018
Address:
De Vries & Metman Overschiestraat 180, 1062 XK, Amsterdam, Netherlands (NL)
To:

Inventor

Name:
Zugmaier, Gerhard
Address:
80336 Munich, Germany (DE)

Priority

1

Priority Patent Number:
221269 P
Priority Date:
29/06/2009
Priority Country:
United States of America (US)

2

Priority Patent Number:
183291 P
Priority Date:
02/06/2009
Priority Country:
United States of America (US)

3

Priority Patent Number:
112323 P
Priority Date:
07/11/2008
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 39/00; C07K 16/28; C07K 16/30; C07K 16/46;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
15/18
Publication date:
04/04/2018
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
51/17
Publication date:
20/12/2017
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201803
Publication date:
17/01/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
201751
Publication date:
20/12/2017
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
30/11/2025
Annual Fee Number:
17
Annual Fee Amount:
1100 Euro
Last Annual Payment Date:
22/10/2024
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
1000 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
29/03/2018 Outgoing Correspondence Letter no formal defects 1 PDF /2/6/7/5/2/0800225762/docs/ep15154416.0_0_200537l271.pdf
15/03/2018 Claims First filed claims 2 PDF /2/6/7/5/2/0800225762/docs/ep15154416.0_1_claims20180315160825207.pdf
15/03/2018 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /2/6/7/5/2/0800225762/docs/ep15154416.0_2_incomingcorrespondenceelectronic20180315160826338.pdf